Menu

Laparoscopic Essure Device Removal (ESSURE)

Status

Unknown

Conditions

Contraception

Study type

Observational

Funder types

Other

Identifiers

NCT04779658
RECHMPL21_0087

Details and patient eligibility

About

In recent years, several symptoms have been attributed to Essure, including pelvic pain and other general symptoms. Consequently, an increasing number of patients request Essure removal for alleged adverse reactions to the device.

Study Objective: To evaluate the quality of life of patients who underwent Essure_ device removal and morbidity of this surgery.

Design: Prospective observational cohort study. Setting: Academic hospitals of La Conception, Marseille, and Arnaud-de-Villeneuve, Montpellier, France.

Patients: Women who underwent Essure_ device removal by salpingectomy, between February 2017 and August 2018.

Methods : The following information have been collected during preoperative clinics: demographic data, medical history, clinical symptoms attributed to the Essure device, time between Essure sterilization and early symptoms, time between the beginning of symptoms and surgical removal. Follow-up visits have benne scheduled at one month and three months post-operation. The evolution of symptoms was collected during the follow-up visit at three months based on clinical reports and a dedicated questionnaire. Evaluation of Quality of life have been evaluated thanks to SF36 and HAD questionnaires. Alle these patients will be contacted by phone call to assess to evolution of symptoms and to complete SF 36 and HAD questionnaires.

Hypothesis : Recovery of symptoms due to ESSURE device and improvement of quality of life after surgery.

Enrollment

90 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >18 years old
  • symptoms related to ESSURE device
  • salpingectomy for ESSURE removal

Exclusion criteria

  • Exclusion criteria were failure to perform a complete removal of the Essure and second surgery to remove fragments left behind from a previous procedure.

Trial contacts and locations

1

There are currently no registered sites for this trial.

Central trial contact

Martha DURAES, MD; GAUTHIER RATHAT

Timeline

Last updated: Mar 03, 2021

Start date

Jan 01, 2021 • 4 years ago

End date

Dec 29, 2021 • 3 years ago

Today

May 06, 2025

Sponsor of this trial

Data sourced from clinicaltrials.gov